Skip to content

A study to compare a new procedure Chivate and conventional hemorrhoid surgery.

A Randomized Control trial to Assess the Efficacy and Safety of Chivates Procedure in Comparison to Conventional open Hemorrhoidectomy - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/07/113488
Enrollment
60
Registered
2026-07-06
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K642- Third degree hemorrhoids Health Condition 2: K643- Fourth degree hemorrhoids

Interventions

Intervention1: Chivates Procedure: Chivates Procedure fot Grade 3 and 4 Hemorhoids Control Intervention1: Open Hemorrhoidectomy: Open Hemorrhoidectomy for Grade 3 and 4 Hemorrhoids

Sponsors

Department of General Surgery UPUMS
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients male and female having grade 3 and 4 hemorrhoids Age 18 to 60 years Patients having under control Hypertension and diabetes mellitus Patients giving consent for surgery

Exclusion criteria

Exclusion criteria: Thrombosed hemorrhoids Ulcerated hemorrhoids Anal stricture Proctitis Suspected rectal or anal growth Previously operated hemorrhoids

Design outcomes

Primary

MeasureTime frame
Efficacy and safety of Chivates procedure in Grade 3 and 4 hemorrhoids in terms of post operative pain intra-operative bleeding and recurrence rate Timepoint: 12 months

Secondary

MeasureTime frame
Hospital stay in both the groups Operative time in both the groups Is there any difference in terms of hospital stay operative time and recurrence rate between the two groups Timepoint: 12 months

Countries

India

Contacts

Public ContactDr Ram Lakhan Singh Verma

UPUMS Saifai, Etawah, U.P. - 206130, India

ramlakhansinghverma@gmail.com08954890686

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026